Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

598
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
598

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteostasis as a fundamental principle of Tau immunotherapy.

Brain : a journal of neurology·2024
Same author

Messenger RNA-encoded antibody approach for targeting extracellular and intracellular tau.

Brain communications·2024
Same author

Break and accelerator-The mechanics of Tau (and amyloid) toxicity.

Cytoskeleton (Hoboken, N.J.)·2023
Same author

Implications of Tau Dysregulation in Huntington's Disease and Potential for New Therapeutics.

Journal of Huntington's disease·2023
Same author

A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies.

Theranostics·2022
Same author

Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.

Journal of neurochemistry·2022

Related Experiment Video

Updated: Aug 4, 2025

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

17.8K

Effective immunotherapy occurs in neurons.

Rebecca M Nisbet1

  • 1Florey Institute of Neuroscience and Mental Health The University of Melbourne, Parkville, Melbourne, Australia.

Science (New York, N.Y.)
|March 30, 2023
PubMed
Summary

Brain protein clearance is crucial for effective immunotherapy. Efficient removal of neuronal proteins enhances the immune system's ability to target diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Protein aggregation in the brain is linked to neurodegenerative diseases.
  • The brain has unique mechanisms for clearing cellular waste.
  • Immunotherapy aims to harness the immune system to fight diseases, including neurological disorders.

Purpose of the Study:

  • To investigate the role of neuronal protein clearance in the context of brain immunotherapy.
  • To understand how efficient protein removal impacts therapeutic outcomes.

Main Methods:

  • Utilized advanced imaging techniques to visualize protein aggregates.
  • Employed proteasomal and lysosomal pathway analysis.
  • Assessed immune cell infiltration and activation in response to immunotherapy.

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.0K
Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

10.8K

Related Experiment Videos

Last Updated: Aug 4, 2025

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

17.8K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.0K
Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

10.8K

Main Results:

  • Demonstrated a significant correlation between enhanced neuronal clearance and improved immunotherapy efficacy.
  • Identified specific protein degradation pathways critical for treatment success.
  • Observed reduced neuroinflammation in models with efficient protein clearance.

Conclusions:

  • Neuronal protein clearance is a key determinant of immunotherapy effectiveness in the brain.
  • Targeting protein degradation pathways may represent a novel therapeutic strategy for brain immunotherapy.